Long‐Term Outcomes of Reduced‐Intensity Conditioning Hematopoietic Stem Cell Transplantation for Patients With Systemic Sclerosis With Impaired Cardiac Function
RIC AHSCT is safe for patients with severe manifestations from SSc. Supplemental oxygen use, elevated BNP, and anti-Scl-70 antibody positivity were risk factors for worse outcomes after RIC AHSCT.
Authors
- Katy Bedjeti (ORCID: https://orcid.org/0000-0001-5910-112X)
- George E. Georges
- Carrie Richardson (ORCID: https://orcid.org/0000-0002-2541-175X)
- Anthony Esposito
- Yonatan Moshe Lean (ORCID: https://orcid.org/0009-0008-4094-6497)
Institutions
- Northwestern University (US)
Publication Details
- Journal
- Arthritis & Rheumatology
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1002/art.70031
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Georgia Clinical and Translational Science Alliance
- National Institutes of Health
- Feinberg School of Medicine